Eledon Pharmaceuticals Ownership 2024 | Who Owns Eledon Pharmaceuticals Now?

OverviewFinancials Chart

Institutional Ownership

60.89%

Insider Ownership

3.41%

Retail Ownership

35.70%

Institutional Holders

31.00

Eledon Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BVF INC/IL	20.98%	0.47%	6,293,282	1,966,572	45.45%	16,614,264	Jun 30, 2024
ARMISTICE CAPITAL, LLC	7.79%	0.08%	2,336,000	39,000	1.70%	6,167,040	Jun 30, 2024
ZIMMER PARTNERS, LP	7.03%	0.10%	2,109,704	2,109,704	100.00%	5,569,619	Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC	5.00%	0.03%	1,500,000	1,449,200	2852.76%	3,960,000	Jun 30, 2024
SPHERA FUNDS MANAGEMENT LTD.	4.32%	0.47%	1,297,021	1,297,021	100.00%	3,424,135	Jun 30, 2024
VANGUARD GROUP INC	3.68%	0.00%	1,104,395	135,274	13.96%	2,915,603	Jun 30, 2024
WOODLINE PARTNERS LP	2.25%	0.02%	675,243	23,304	3.57%	1,782,642	Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC	2.00%	0.09%	600,000	600,000	100.00%	1,584,000	Jun 30, 2024
ALYESKA INVESTMENT GROUP, L.P.	1.67%	0.01%	500,000	500,000	100.00%	1,320,000	Jun 30, 2024
ENSIGN PEAK ADVISORS, INC	1.48%	0.00%	443,001	-	-	1,169,523	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	1.15%	0.00%	344,489	163,588	90.43%	909,619	Jun 30, 2024
STATE STREET CORP	0.54%	-	161,492	116,800	261.34%	426,339,000	Jun 30, 2024
CM MANAGEMENT, LLC	0.53%	0.39%	160,000	-	-	422,400	Jun 30, 2024
BLACKROCK INC.	0.52%	-	155,080	128,249	477.99%	409,411	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.46%	0.00%	136,773	49,704	57.09%	361,081	Jun 30, 2024
NORTHERN TRUST CORP	0.31%	-	91,893	52,089	130.86%	242,598,000	Jun 30, 2024
JMAC ENTERPRISES LLC	0.19%	0.03%	58,041	-	-	153,228	Jun 30, 2024
UBS GROUP AG	0.18%	-	55,001	54,997	1374925.00%	145,203	Jun 30, 2024
INGALLS & SNYDER LLC	0.17%	0.01%	51,849	-	-	137,000	Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.11%	0.00%	33,400	33,400	100.00%	88,176	Jun 30, 2024

Eledon Pharmaceuticals's largest institutional shareholder is BVF INC/IL, holding 20.98% of the company's total share outstanding, currently valued at $16.61M. The top 10 institutional shareholders own together 56.22% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SPHERA FUNDS MANAGEMENT LTD.	4.32%	0.47%	1,297,021	1,297,021	100.00%	3,424,135	Jun 30, 2024
BVF INC/IL	20.98%	0.47%	6,293,282	1,966,572	45.45%	16,614,264	Jun 30, 2024
CM MANAGEMENT, LLC	0.53%	0.39%	160,000	-	-	422,400	Jun 30, 2024
ZIMMER PARTNERS, LP	7.03%	0.10%	2,109,704	2,109,704	100.00%	5,569,619	Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC	2.00%	0.09%	600,000	600,000	100.00%	1,584,000	Jun 30, 2024
ARMISTICE CAPITAL, LLC	7.79%	0.08%	2,336,000	39,000	1.70%	6,167,040	Jun 30, 2024
JMAC ENTERPRISES LLC	0.19%	0.03%	58,041	-	-	153,228	Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC	5.00%	0.03%	1,500,000	1,449,200	2852.76%	3,960,000	Jun 30, 2024
WOODLINE PARTNERS LP	2.25%	0.02%	675,243	23,304	3.57%	1,782,642	Jun 30, 2024
ALYESKA INVESTMENT GROUP, L.P.	1.67%	0.01%	500,000	500,000	100.00%	1,320,000	Jun 30, 2024
MARCO INVESTMENT MANAGEMENT LLC	0.10%	0.01%	30,344	5,535	22.31%	80,108	Jun 30, 2024
INGALLS & SNYDER LLC	0.17%	0.01%	51,849	-	-	137,000	Jun 30, 2024
ENSIGN PEAK ADVISORS, INC	1.48%	0.00%	443,001	-	-	1,169,523	Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.11%	0.00%	33,400	33,400	100.00%	88,176	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.06%	0.00%	16,958	11,284	198.87%	44,769	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.46%	0.00%	136,773	49,704	57.09%	361,081	Jun 30, 2024
PATHSTONE HOLDINGS, LLC	0.04%	0.00%	13,029	-	-	34,397	Jun 30, 2024
MERCER GLOBAL ADVISORS INC /ADV	0.06%	0.00%	16,726	-	-	44,157	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	1.15%	0.00%	344,489	163,588	90.43%	909,619	Jun 30, 2024
VANGUARD GROUP INC	3.68%	0.00%	1,104,395	135,274	13.96%	2,915,603	Jun 30, 2024

The largest Eledon Pharmaceuticals shareholder by % of total assets is SPHERA FUNDS MANAGEMENT LTD.. The company owns 1.30M shares of Eledon Pharmaceuticals (ELDN), representing 0.47% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ZIMMER PARTNERS, LP	7.03%	0.10%	2,109,704	2,109,704	100.00%	5,569,619	Jun 30, 2024
BVF INC/IL	20.98%	0.47%	6,293,282	1,966,572	45.45%	16,614,264	Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC	5.00%	0.03%	1,500,000	1,449,200	2852.76%	3,960,000	Jun 30, 2024
SPHERA FUNDS MANAGEMENT LTD.	4.32%	0.47%	1,297,021	1,297,021	100.00%	3,424,135	Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC	2.00%	0.09%	600,000	600,000	100.00%	1,584,000	Jun 30, 2024
ALYESKA INVESTMENT GROUP, L.P.	1.67%	0.01%	500,000	500,000	100.00%	1,320,000	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	1.15%	0.00%	344,489	163,588	90.43%	909,619	Jun 30, 2024
VANGUARD GROUP INC	3.68%	0.00%	1,104,395	135,274	13.96%	2,915,603	Jun 30, 2024
BLACKROCK INC.	0.52%	-	155,080	128,249	477.99%	409,411	Jun 30, 2024
STATE STREET CORP	0.54%	-	161,492	116,800	261.34%	426,339,000	Jun 30, 2024
UBS GROUP AG	0.18%	-	55,001	54,997	1374925.00%	145,203	Jun 30, 2024
NORTHERN TRUST CORP	0.31%	-	91,893	52,089	130.86%	242,598,000	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.46%	0.00%	136,773	49,704	57.09%	361,081	Jun 30, 2024
ARMISTICE CAPITAL, LLC	7.79%	0.08%	2,336,000	39,000	1.70%	6,167,040	Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.11%	0.00%	33,400	33,400	100.00%	88,176	Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP	0.10%	-	30,233	30,233	100.00%	79,815	Jun 30, 2024
WOODLINE PARTNERS LP	2.25%	0.02%	675,243	23,304	3.57%	1,782,642	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.06%	0.00%	16,958	11,284	198.87%	44,769	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.02%	-	6,818	6,818	100.00%	18,000	Jun 30, 2024
MARCO INVESTMENT MANAGEMENT LLC	0.10%	0.01%	30,344	5,535	22.31%	80,108	Jun 30, 2024

As of Jun 30 2024, Eledon Pharmaceuticals's largest institutional buyer is ZIMMER PARTNERS, LP. The company purchased 2.11M stocks of ELDN, valued at $5.57M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MILLENNIUM MANAGEMENT LLC	-	-	-	-13,875	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-189	-100.00%	-	Jun 30, 2024
GROUP ONE TRADING, L.P.	-	-	-	-22	-100.00%	-	Jun 30, 2024
CM MANAGEMENT, LLC	0.53%	0.39%	160,000	-	-	422,400	Jun 30, 2024
JMAC ENTERPRISES LLC	0.19%	0.03%	58,041	-	-	153,228	Jun 30, 2024
INGALLS & SNYDER LLC	0.17%	0.01%	51,849	-	-	137,000	Jun 30, 2024
ENSIGN PEAK ADVISORS, INC	1.48%	0.00%	443,001	-	-	1,169,523	Jun 30, 2024
PATHSTONE HOLDINGS, LLC	0.04%	0.00%	13,029	-	-	34,397	Jun 30, 2024
MERCER GLOBAL ADVISORS INC /ADV	0.06%	0.00%	16,726	-	-	44,157	Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.05%	-	14,987	-	-	39,566	Jun 30, 2024
MORGAN STANLEY	0.01%	-	2,155	-	-	5,689	Jun 30, 2024
FMR LLC	0.00%	-	17	-	-	45	Jun 30, 2024
JPMORGAN CHASE & CO	0.00%	-	91	35	62.50%	240	Jun 30, 2024
MARCO INVESTMENT MANAGEMENT LLC	0.10%	0.01%	30,344	5,535	22.31%	80,108	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.02%	-	6,818	6,818	100.00%	18,000	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.06%	0.00%	16,958	11,284	198.87%	44,769	Jun 30, 2024
WOODLINE PARTNERS LP	2.25%	0.02%	675,243	23,304	3.57%	1,782,642	Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP	0.10%	-	30,233	30,233	100.00%	79,815	Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.11%	0.00%	33,400	33,400	100.00%	88,176	Jun 30, 2024
ARMISTICE CAPITAL, LLC	7.79%	0.08%	2,336,000	39,000	1.70%	6,167,040	Jun 30, 2024

As of Jun 30 2024, Eledon Pharmaceuticals's biggest institutional seller is MILLENNIUM MANAGEMENT LLC. The company sold -13.88K shares of ELDN, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ZIMMER PARTNERS, LP	7.03%	0.10%	2,109,704	2,109,704	100.00%	5,569,619	Jun 30, 2024
SPHERA FUNDS MANAGEMENT LTD.	4.32%	0.47%	1,297,021	1,297,021	100.00%	3,424,135	Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC	2.00%	0.09%	600,000	600,000	100.00%	1,584,000	Jun 30, 2024
ALYESKA INVESTMENT GROUP, L.P.	1.67%	0.01%	500,000	500,000	100.00%	1,320,000	Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.11%	0.00%	33,400	33,400	100.00%	88,176	Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP	0.10%	-	30,233	30,233	100.00%	79,815	Jun 30, 2024

Eledon Pharmaceuticals's largest new institutional shareholder by number of shares is ZIMMER PARTNERS, LP, purchased 2.11M shares, valued at $5.57M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MILLENNIUM MANAGEMENT LLC	-	-	-	-13,875	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-189	-100.00%	-	Jun 30, 2024
GROUP ONE TRADING, L.P.	-	-	-	-22	-100.00%	-	Jun 30, 2024

Eledon Pharmaceuticals's largest sold out institutional shareholder by shares sold is MILLENNIUM MANAGEMENT LLC, sold -13.88K shares, valued at -, as of undefined.

Eledon Pharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY ADVISOR SERIES VII	0.01%	114,789	-	-	Jan 31, 2024
VANGUARD INDEX FUNDS	0.00%	955,721	51,409	5.68%	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	170,684	3,977	2.39%	Feb 29, 2024
FIDELITY SELECT PORTFOLIOS	0.00%	42,236	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	13,263	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	14,987	-	-	Jan 31, 2024
NATIONWIDE MUTUAL FUNDS	0.00%	26,400	-	-	Jan 31, 2024
Dimensional ETF Trust	0.00%	7,769	-	-	Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	10,185	-	-	Jan 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	2,323	-	-	Jan 31, 2024
Blackstone Alternative Investment Funds	0.00%	300	-	-	Mar 31, 2024
EQ ADVISORS TRUST	0.00%	1,433	-	-	Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	333	-449	-57.42%	Mar 31, 2024

Eledon Pharmaceuticals's largest mutual fund holder by % of total assets is "FIDELITY ADVISOR SERIES VII", owning 114.79K shares, compromising 0.01% of its total assets.

Eledon Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	31	3.33%
31 Mar, 24	30	3.45%
31 Dec, 23	29	3.57%
30 Sep, 23	28	-15.15%
30 Jun, 23	33	6.45%
31 Mar, 23	31	10.71%
31 Dec, 22	28	-3.45%
30 Sep, 22	29	-
30 Jun, 22	29	-9.38%
31 Mar, 22	32	-8.57%
31 Dec, 21	35	9.38%
30 Sep, 21	32	3.23%
30 Jun, 21	31	-3.13%
31 Mar, 21	32	3100.00%
31 Dec, 20	1	-

As of 30 Jun 24, 31 institutions are holding Eledon Pharmaceuticals's shares, representing an increase of 3.33% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	18,259,810	90.30%
31 Mar, 24	9,595,061	4.83%
31 Dec, 23	9,153,168	2.64%
30 Sep, 23	8,917,867	-3.86%
30 Jun, 23	9,275,490	48.63%
31 Mar, 23	6,240,661	-0.17%
31 Dec, 22	6,251,160	-0.27%
30 Sep, 22	6,268,078	-4.08%
30 Jun, 22	6,534,651	-6.71%
31 Mar, 22	7,004,981	-11.16%
31 Dec, 21	7,884,711	-6.52%
30 Sep, 21	8,434,580	-10.49%
30 Jun, 21	9,423,462	13.29%
31 Mar, 21	8,317,697	22933.69%
31 Dec, 20	36,111	-

Eledon Pharmaceuticals (ELDN) has 18.26M shares outstanding as of 30 Jun 24, up 90.30% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	60.89%	3.88%
31 Mar, 24	39.63%	4.25%
31 Dec, 23	30.54%	2.21%
30 Sep, 23	37.15%	0.88%
30 Jun, 23	64.93%	3.40%
31 Mar, 23	43.68%	2.28%
31 Dec, 22	43.76%	2.27%
30 Sep, 22	43.94%	2.09%
30 Jun, 22	45.81%	1.92%
31 Mar, 22	48.88%	1.73%
31 Dec, 21	53.22%	1.64%
30 Sep, 21	56.93%	1.41%
30 Jun, 21	63.60%	2.02%
31 Mar, 21	56.08%	94594.21%
31 Dec, 20	0.24%	-

As of 30 Jun 24, Eledon Pharmaceuticals is held by 60.89% institutional shareholders, representing a 3.88% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	21	90.91%
31 Mar, 24	11	-8.33%
31 Dec, 23	12	9.09%
30 Sep, 23	11	-31.25%
30 Jun, 23	16	60.00%
31 Mar, 23	10	11.11%
31 Dec, 22	9	28.57%
30 Sep, 22	7	40.00%
30 Jun, 22	5	-54.55%
31 Mar, 22	11	-26.67%
31 Dec, 21	15	-
30 Sep, 21	15	-16.67%
30 Jun, 21	18	-41.94%
31 Mar, 21	31	3000.00%
31 Dec, 20	1	-

21 institutional shareholders have increased their position in ELDN stock as of 30 Jun 24 compared to 11 in the previous quarter (a 90.91% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	1	-85.71%
31 Mar, 24	7	16.67%
31 Dec, 23	6	-33.33%
30 Sep, 23	9	80.00%
30 Jun, 23	5	25.00%
31 Mar, 23	4	-50.00%
31 Dec, 22	8	-27.27%
30 Sep, 22	11	10.00%
30 Jun, 22	10	25.00%
31 Mar, 22	8	33.33%
31 Dec, 21	6	-45.45%
30 Sep, 21	11	83.33%
30 Jun, 21	6	-
31 Mar, 21	-	-
31 Dec, 20	-	-

1 institutional shareholders have reduced their position in ELDN stock as of 30 Jun 24 compared to 7 in the previous quarter (a -85.71% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	31	3.33%	18,259,810	90.30%	60.89%	3.88%	21	90.91%	1	-85.71%
31 Mar, 24	30	3.45%	9,595,061	4.83%	39.63%	4.25%	11	-8.33%	7	16.67%
31 Dec, 23	29	3.57%	9,153,168	2.64%	30.54%	2.21%	12	9.09%	6	-33.33%
30 Sep, 23	28	-15.15%	8,917,867	-3.86%	37.15%	0.88%	11	-31.25%	9	80.00%
30 Jun, 23	33	6.45%	9,275,490	48.63%	64.93%	3.40%	16	60.00%	5	25.00%
31 Mar, 23	31	10.71%	6,240,661	-0.17%	43.68%	2.28%	10	11.11%	4	-50.00%
31 Dec, 22	28	-3.45%	6,251,160	-0.27%	43.76%	2.27%	9	28.57%	8	-27.27%
30 Sep, 22	29	-	6,268,078	-4.08%	43.94%	2.09%	7	40.00%	11	10.00%
30 Jun, 22	29	-9.38%	6,534,651	-6.71%	45.81%	1.92%	5	-54.55%	10	25.00%
31 Mar, 22	32	-8.57%	7,004,981	-11.16%	48.88%	1.73%	11	-26.67%	8	33.33%
31 Dec, 21	35	9.38%	7,884,711	-6.52%	53.22%	1.64%	15	-	6	-45.45%
30 Sep, 21	32	3.23%	8,434,580	-10.49%	56.93%	1.41%	15	-16.67%	11	83.33%
30 Jun, 21	31	-3.13%	9,423,462	13.29%	63.60%	2.02%	18	-41.94%	6	-
31 Mar, 21	32	3100.00%	8,317,697	22933.69%	56.08%	94594.21%	31	3000.00%	-	-
31 Dec, 20	1	-	36,111	-	0.24%	-	1	-	-	-

Eledon Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 13, 2024	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	1,031,385	$2.37	$2.44M	3,361,803
May 13, 2024	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	3,173,135	-	$3.17K	3,173,135
May 13, 2024	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	821,121	$2.37	$1.95M	2,633,679
May 13, 2024	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	2,526,238	-	$2.53K	2,526,238
May 13, 2024	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	232,068	-	$232.07	232,068
May 13, 2024	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	75,431	$2.37	$178.77K	220,460
May 09, 2023	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	3,084,090	$3.00	$9.25M	3,084,090
May 09, 2023	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	2,446,209	$3.00	$7.34M	2,446,209
May 09, 2023	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	1,055,445	$2.31	$2.44M	2,330,418
May 09, 2023	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	2,028,645	-	$2.03K	2,028,645
May 09, 2023	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	837,146	$2.31	$1.93M	1,812,558
May 09, 2023	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	1,609,063	-	$1.61K	1,609,063

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 13, 2024	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	1,031,385	$2.37	$2.44M	3,361,803
May 13, 2024	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	3,173,135	-	$3.17K	3,173,135
May 13, 2024	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	821,121	$2.37	$1.95M	2,633,679
May 13, 2024	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	2,526,238	-	$2.53K	2,526,238
May 13, 2024	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	232,068	-	$232.07	232,068
May 13, 2024	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	75,431	$2.37	$178.77K	220,460
May 09, 2023	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	3,084,090	$3.00	$9.25M	3,084,090
May 09, 2023	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	2,446,209	$3.00	$7.34M	2,446,209
May 09, 2023	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	1,055,445	$2.31	$2.44M	2,330,418
May 09, 2023	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	2,028,645	-	$2.03K	2,028,645
May 09, 2023	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	837,146	$2.31	$1.93M	1,812,558
May 09, 2023	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	1,609,063	-	$1.61K	1,609,063

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 14, 2024	Gros David-Alexandre C	director, officer	Chief Executive Officer	A-Award	Buy	517,454	$2.30	$1.19M	517,454
Jun 14, 2024	Little Paul Sean	officer	Chief Financial Officer	A-Award	Buy	267,470	$2.30	$615.18K	267,470
Jun 14, 2024	Perrin Steven	director, officer	President	A-Award	Buy	428,148	$2.30	$984.74K	428,148
Jun 14, 2024	Smith Bryan E.	officer	General Counsel, Corporate Sec	A-Award	Buy	241,650	$2.30	$555.79K	241,650
May 13, 2024	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	1,031,385	$2.37	$2.44M	3,361,803
May 13, 2024	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	3,173,135	-	$3.17K	3,173,135
May 13, 2024	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	821,121	$2.37	$1.95M	2,633,679
May 13, 2024	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	2,526,238	-	$2.53K	2,526,238
May 13, 2024	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	232,068	-	$232.07	232,068
May 13, 2024	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	75,431	$2.37	$178.77K	220,460
Oct 03, 2023	Robinson James A. Jr.	director	-	A-Award	Buy	150,437	$1.55	$233.18K	150,437
Oct 03, 2023	Kirk Allan	director	-	A-Award	Buy	150,437	$1.55	$233.18K	150,437
Oct 02, 2023	Robinson James A. Jr.	director			Buy	-	-	-	-
Oct 02, 2023	Kirk Allan	director			Buy	-	-	-	-
May 09, 2023	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	3,084,090	$3.00	$9.25M	3,084,090
May 09, 2023	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	2,446,209	$3.00	$7.34M	2,446,209
May 09, 2023	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	1,055,445	$2.31	$2.44M	2,330,418
May 09, 2023	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	2,028,645	-	$2.03K	2,028,645
May 09, 2023	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	837,146	$2.31	$1.93M	1,812,558
May 09, 2023	BVF PARTNERS L P/IL	10 percent owner	-	P-Purchase	Buy	1,609,063	-	$1.61K	1,609,063

The last insider buy of ELDN was made by BVF PARTNERS L P/IL on May 13 2024, buying 1,031,385 shares at $2.37 per share (worth $2.44M).

Eledon Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	10	-	-
Q4 2023	2	-	-
Q2 2023	19	-	-
Q1 2023	11	-	-
Q4 2022	1	-	-
Q1 2022	10	8	125.00%
Q4 2021	1	-	-
Q3 2021	1	1	100.00%
Q2 2021	3	-	-
Q1 2021	-	1	-
Q4 2020	13	15	86.67%
Q3 2020	5	11	45.45%
Q1 2020	5	-	-
Q3 2019	8	-	-
Q2 2019	4	7	57.14%
Q1 2019	5	-	-
Q3 2018	3	-	-
Q2 2018	4	-	-
Q1 2018	6	-	-
Q4 2017	1	-	-

10 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Eledon Pharmaceuticals's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	6	-	-
Q4 2023	-	-	-
Q2 2023	9	-	-
Q1 2023	-	-	-
Q4 2022	1	-	-
Q1 2022	-	-	-
Q4 2021	1	-	-
Q3 2021	1	-	-
Q2 2021	2	-	-
Q1 2021	-	-	-
Q4 2020	7	3	233.33%
Q3 2020	-	-	-
Q1 2020	-	2	-
Q3 2019	-	-	-
Q2 2019	4	7	57.14%
Q1 2019	-	-	-
Q3 2018	3	-	-
Q2 2018	-	-	-
Q1 2018	-	-	-
Q4 2017	-	-	-

As of Q2 2024, Insider owners conducted 6 open market buy trades and 0 open market sell trades of Eledon Pharmaceuticals's stocks.

Eledon Pharmaceuticals Peer Ownership

Ticker	Company
XFOR	X4 Pharmaceuticals, Inc.
MREO	Mereo BioPharma Group plc
DAWN	Day One Biopharmaceuticals, Inc.
HOOK	HOOKIPA Pharma Inc.
TERN	Terns Pharmaceuticals, Inc.
INZY	Inozyme Pharma, Inc.
ABOS	Acumen Pharmaceuticals, Inc.
AMLX	Amylyx Pharmaceuticals, Inc.

ELDN Ownership FAQ

Who Owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals is owned by institutional shareholders (60.89%), insiders (3.41%), and public (35.70%). The largest institutional shareholder of Eledon Pharmaceuticals is BVF INC/IL (20.98% of total shares) and the top mutual fund owner is FIDELITY ADVISOR SERIES VII (0.01% of total shares).

Who are the major institutional shareholders of Eledon Pharmaceuticals?

Eledon Pharmaceuticals's major institutional shareholders are BVF INC/IL, ARMISTICE CAPITAL, LLC, ZIMMER PARTNERS, LP, SCHONFELD STRATEGIC ADVISORS LLC, and SPHERA FUNDS MANAGEMENT LTD.. The top five shareholders own together 45.14% of the company's share outstanding.

How many Eledon Pharmaceuticals shareholders are there?

As of Jun 2024, there are 31 institutional shareholders of Eledon Pharmaceuticals.

What percentage of Eledon Pharmaceuticals is owned by BVF INC/IL?

BVF INC/IL owns 6.29M shares of Eledon Pharmaceuticals, representing 20.98% of the company's total shares outstanding, valued at $16.61M (as of Jun 2024).

What percentage of Eledon Pharmaceuticals is owned by ARMISTICE CAPITAL, LLC?

As of Jun 2024, ARMISTICE CAPITAL, LLC holds 2.34M shares of Eledon Pharmaceuticals (ELDN), compromising 7.79% of the company, valued at $6.17M.

What percentage of Eledon Pharmaceuticals is owned by ZIMMER PARTNERS, LP?

ZIMMER PARTNERS, LP is the third largest holder of Eledon Pharmaceuticals. The company owns 2.11M of the company's shares outstanding (worth $5.57M).